Year |
Citation |
Score |
2022 |
Hunt C, Stout DM, Tie Z, Acheson D, Colvonen PJ, Nievergelt CM, Yurgil KA, Baker DG, Risbrough VB. Pre-deployment threat learning predicts increased risk for post-deployment insomnia: Evidence from the Marine Resiliency Study. Behaviour Research and Therapy. 159: 104223. PMID 36327523 DOI: 10.1016/j.brat.2022.104223 |
0.378 |
|
2022 |
Acheson DT, Baker DG, Nievergelt CM, Yurgil KA, Geyer MA, Risbrough VB. Prospective longitudinal assessment of sensorimotor gating as a risk/resiliency factor for posttraumatic stress disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 36192631 DOI: 10.1038/s41386-022-01460-9 |
0.303 |
|
2019 |
Acheson DT, Kwan B, Maihofer AX, Risbrough VB, Nievergelt CM, Clark JW, Tu XM, Irwin MR, Baker DG. Sleep disturbance at pre-deployment is a significant predictor of post-deployment re-experiencing symptoms. European Journal of Psychotraumatology. 10: 1679964. PMID 31723377 DOI: 10.1080/20008198.2019.1679964 |
0.321 |
|
2019 |
Stout DM, Glenn DE, Acheson DT, Simmons AN, Risbrough VB. Characterizing the Neural Circuitry Associated with Configural Threat Learning. Brain Research. PMID 31173725 DOI: 10.1016/J.Brainres.2019.06.003 |
0.449 |
|
2019 |
Colvonen PJ, Straus LD, Acheson D, Gehrman P. A Review of the Relationship Between Emotional Learning and Memory, Sleep, and PTSD. Current Psychiatry Reports. 21: 2. PMID 30661137 DOI: 10.1007/S11920-019-0987-2 |
0.466 |
|
2018 |
Straus LD, Norman SB, Risbrough VB, Acheson DT, Drummond SPA. REM sleep and safety signal learning in posttraumatic stress disorder: A preliminary study in military veterans. Neurobiology of Stress. 9: 22-28. PMID 30116769 DOI: 10.1016/J.Ynstr.2018.07.001 |
0.443 |
|
2018 |
Stout DM, Glenn DE, Acheson DT, Spadoni AD, Risbrough VB, Simmons AN. Neural measures associated with configural threat acquisition. Neurobiology of Learning and Memory. 150: 99-106. PMID 29544725 DOI: 10.1016/J.Nlm.2018.03.012 |
0.446 |
|
2018 |
Stout DM, Acheson DT, Moore TM, Gur RC, Baker DG, Geyer MA, Risbrough VB. Individual variation in working memory is associated with fear extinction performance. Behaviour Research and Therapy. 102: 52-59. PMID 29331727 DOI: 10.1016/J.Brat.2018.01.002 |
0.509 |
|
2017 |
Glenn DE, Risbrough VB, Simmons AN, Acheson DT, Stout DM. The Future of Contextual Fear Learning for PTSD Research: A Methodological Review of Neuroimaging Studies. Current Topics in Behavioral Neurosciences. PMID 29063483 DOI: 10.1007/7854_2017_30 |
0.547 |
|
2017 |
Deslauriers J, Acheson DT, Maihofer AX, Nievergelt CM, Baker DG, Geyer MA, Risbrough VB. COMT val158met polymorphism links to altered fear conditioning and extinction are modulated by PTSD and childhood trauma. Depression and Anxiety. PMID 28833952 DOI: 10.1002/Da.22678 |
0.485 |
|
2017 |
Straus LD, Acheson DT, Risbrough VB, Drummond SPA. Sleep Deprivation Disrupts Recall of Conditioned Fear Extinction. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 123-129. PMID 28758152 DOI: 10.1016/J.Bpsc.2016.05.004 |
0.499 |
|
2017 |
Glenn DE, Acheson DT, Geyer MA, Nievergelt CM, Baker DG, Risbrough VB. Fear learning alterations after traumatic brain injury and their role in development of posttraumatic stress symptoms. Depression and Anxiety. PMID 28489272 DOI: 10.1002/Da.22642 |
0.459 |
|
2017 |
Straus L, Acheson D, Risbrough V, Drummond S, Norman S. 1073 SLEEP, FEAR CONDITIONING, AND SAFETY SIGNAL LEARNING IN VETERANS WITH PTSD Sleep. 40: A400-A400. DOI: 10.1093/Sleepj/Zsx050.1072 |
0.474 |
|
2017 |
Risbrough V, Geyer M, Acheson D, Minassian A, Maihofer A, Baker D, Nievergelt C. 88. Identification of Psychophysiological Markers of PTSD Risk and Potential Use as Intermediate Phenotypes Biological Psychiatry. 81: S37. DOI: 10.1016/J.Biopsych.2017.02.100 |
0.308 |
|
2016 |
Glenn DE, Acheson DT, Geyer MA, Nievergelt CM, Baker DG, Risbrough VB. HIGH AND LOW THRESHOLD FOR STARTLE REACTIVITY ASSOCIATED WITH PTSD SYMPTOMS BUT NOT PTSD RISK: EVIDENCE FROM A PROSPECTIVE STUDY OF ACTIVE DUTY MARINES. Depression and Anxiety. PMID 26878585 DOI: 10.1002/Da.22475 |
0.366 |
|
2015 |
Acheson DT, Eyler LT, Resovsky J, Tsan E, Risbrough VB. Fear extinction memory performance in a sample of stable, euthymic patients with bipolar disorder. Journal of Affective Disorders. 185: 230-8. PMID 26247493 DOI: 10.1016/J.Jad.2015.06.053 |
0.437 |
|
2015 |
Acheson DT, Risbrough VB. Oxytocin enhancement of fear extinction: a new target for facilitating exposure-based treatments? Biological Psychiatry. 78: 154-5. PMID 26143973 DOI: 10.1016/J.Biopsych.2015.06.002 |
0.528 |
|
2015 |
Acheson DT, Feifel D, Kamenski M, Mckinney R, Risbrough VB. Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response. Depression and Anxiety. 32: 400-7. PMID 25826649 DOI: 10.1002/Da.22362 |
0.437 |
|
2015 |
Acheson DT, Geyer MA, Baker DG, Nievergelt CM, Yurgil K, Risbrough VB. Conditioned fear and extinction learning performance and its association with psychiatric symptoms in active duty Marines. Psychoneuroendocrinology. 51: 495-505. PMID 25444643 DOI: 10.1016/J.Psyneuen.2014.09.030 |
0.485 |
|
2014 |
Marshall AJ, Acheson DT, Risbrough VB, Straus LD, Drummond SP. Fear conditioning, safety learning, and sleep in humans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 11754-60. PMID 25164670 DOI: 10.1523/Jneurosci.0478-14.2014 |
0.414 |
|
2014 |
Acheson DT, Geyer MA, Risbrough VB. Psychophysiology in the study of psychological trauma: where are we now and where do we need to be? Current Topics in Behavioral Neurosciences. 21: 157-83. PMID 25158622 DOI: 10.1007/7854_2014_346 |
0.413 |
|
2013 |
Acheson DT, Twamley EW, Young JW. Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development. Frontiers in Neuroscience. 7: 103. PMID 23785309 DOI: 10.3389/Fnins.2013.00103 |
0.318 |
|
2013 |
Acheson D, Feifel D, de Wilde S, McKinney R, Lohr J, Risbrough V. The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample. Psychopharmacology. 229: 199-208. PMID 23644911 DOI: 10.1007/S00213-013-3099-4 |
0.547 |
|
2012 |
Acheson DT, Stein MB, Paulus MP, Ravindran L, Simmons AN, Lohr JB, Risbrough VB. Effects of anxiolytic treatment on potentiated startle during aversive image anticipation. Human Psychopharmacology. 27: 419-27. PMID 22782542 DOI: 10.1002/Hup.2243 |
0.355 |
|
2012 |
Acheson DT, Forsyth JP, Moses E. Interoceptive fear conditioning and panic disorder: the role of conditioned stimulus-unconditioned stimulus predictability. Behavior Therapy. 43: 174-89. PMID 22304889 DOI: 10.1016/J.Beth.2011.06.001 |
0.618 |
|
2012 |
Acheson DT, Gresack JE, Risbrough VB. Hippocampal dysfunction effects on context memory: possible etiology for posttraumatic stress disorder. Neuropharmacology. 62: 674-85. PMID 21596050 DOI: 10.1016/J.Neuropharm.2011.04.029 |
0.472 |
|
2007 |
Acheson DT, Forsyth JP, Prenoveau JM, Bouton ME. Interoceptive fear conditioning as a learning model of panic disorder: an experimental evaluation using 20% CO(2)-enriched air in a non-clinical sample. Behaviour Research and Therapy. 45: 2280-94. PMID 17548049 DOI: 10.1016/J.Brat.2007.04.008 |
0.703 |
|
2007 |
Forsyth JP, Barrios V, Acheson DT. Exposure therapy and cognitive interventions for the anxiety disorders: Overview and newer third-generation perspectives Handbook of Exposure Therapies. 61-108. DOI: 10.1016/B978-012587421-2/50004-1 |
0.654 |
|
Show low-probability matches. |